Jennifer Schneiderman

3.9k total citations · 2 hit papers
45 papers, 1.9k citations indexed

About

Jennifer Schneiderman is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jennifer Schneiderman has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 14 papers in Immunology and 9 papers in Oncology. Recurrent topics in Jennifer Schneiderman's work include Hematopoietic Stem Cell Transplantation (18 papers), Complement system in diseases (6 papers) and Acute Myeloid Leukemia Research (6 papers). Jennifer Schneiderman is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Complement system in diseases (6 papers) and Acute Myeloid Leukemia Research (6 papers). Jennifer Schneiderman collaborates with scholars based in United States, Germany and Greece. Jennifer Schneiderman's co-authors include Nancy M. Dunbar, Huy P. Pham, Nicole A. Aqui, Reinhard Klingel, Laura Connelly‐Smith, Volker Witt, Nicole D. Zantek, Yanyun Wu, Erin Meyer and Rasheed A. Balogun and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Jennifer Schneiderman

40 papers receiving 1.9k citations

Hit Papers

Guidelines on the Use of ... 2019 2026 2021 2023 2019 2023 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Schneiderman United States 15 732 484 360 310 283 45 1.9k
Huy P. Pham United States 18 773 1.1× 639 1.3× 441 1.2× 360 1.2× 366 1.3× 91 2.4k
Erin Meyer United States 13 621 0.8× 373 0.8× 418 1.2× 194 0.6× 222 0.8× 31 1.6k
Laura Connelly‐Smith United States 12 940 1.3× 784 1.6× 544 1.5× 352 1.1× 425 1.5× 32 2.6k
Nicholas Bandarenko United States 19 616 0.8× 697 1.4× 321 0.9× 143 0.5× 328 1.2× 36 1.9k
David Sutton Canada 25 884 1.2× 590 1.2× 456 1.3× 347 1.1× 166 0.6× 57 2.2k
Fatma Gümrük Türkiye 23 817 1.1× 305 0.6× 497 1.4× 102 0.3× 170 0.6× 200 2.0k
Wolfgang Miesbach Germany 27 1.7k 2.3× 288 0.6× 371 1.0× 202 0.7× 314 1.1× 192 3.2k
C.J. Haagsma Netherlands 20 855 1.2× 479 1.0× 445 1.2× 76 0.2× 266 0.9× 38 2.8k
John Lazarchick United States 25 883 1.2× 231 0.5× 309 0.9× 85 0.3× 285 1.0× 135 2.0k
J Hermans Netherlands 27 818 1.1× 306 0.6× 224 0.6× 114 0.4× 321 1.1× 58 2.0k

Countries citing papers authored by Jennifer Schneiderman

Since Specialization
Citations

This map shows the geographic impact of Jennifer Schneiderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Schneiderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Schneiderman more than expected).

Fields of papers citing papers by Jennifer Schneiderman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Schneiderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Schneiderman. The network helps show where Jennifer Schneiderman may publish in the future.

Co-authorship network of co-authors of Jennifer Schneiderman

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Schneiderman. A scholar is included among the top collaborators of Jennifer Schneiderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Schneiderman. Jennifer Schneiderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olson, Timothy S., Alexis A. Thompson, Janet L. Kwiatkowski, et al.. (2025). Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy Results in Durable Hemoglobin A (HbA) Production with up to 10 Years of Follow-up in Participants with Transfusion-Dependent β-Thalassemia. Transplantation and Cellular Therapy. 31(2). S20–S20.
2.
Liu, Hien, Leon Su, Jeffrey L. Winters, et al.. (2022). Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis. Cytotherapy. 24(9). 916–922. 5 indexed citations
3.
Thibodeaux, Suzanne R., Nicole A. Aqui, Yara A. Park, et al.. (2022). Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies. Journal of Clinical Apheresis. 37(3). 223–236. 10 indexed citations
4.
Giardino, Stefano, Stefano Volpi, Roberta Caorsi, et al.. (2022). Hematopoietic Stem Cell Transplantation in ARPC1B Deficiency. Journal of Clinical Immunology. 42(7). 1535–1544. 7 indexed citations
5.
Sharma, Ruchika, et al.. (2020). A Novel Mutation in WAS Gene Causing a Phenotypic Presentation of Wiskott-Aldrich Syndrome: A Case Report. Journal of Pediatric Hematology/Oncology. 43(2). e234–e236. 2 indexed citations
6.
Balogun, Rasheed A., Amber P. Sanchez, Reinhard Klingel, et al.. (2020). Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA‐associated vasculitis. Journal of Clinical Apheresis. 35(5). 493–499. 20 indexed citations
7.
Edelson, Richard L., Yanyun Wu, & Jennifer Schneiderman. (2018). American council on ECP (ACE): Why now?. Journal of Clinical Apheresis. 33(4). 464–468. 28 indexed citations
8.
Broglie, Larisa, Alfred Rademaker, John P. Galvin, et al.. (2018). Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease. Hematology/Oncology and Stem Cell Therapy. 11(3). 169–174. 3 indexed citations
9.
DeSimone, Robert A., Joseph E. Schwartz, & Jennifer Schneiderman. (2017). Extracorporeal photopheresis in pediatric patients: Practical and technical considerations. Journal of Clinical Apheresis. 32(6). 543–552. 13 indexed citations
10.
Ward, Jessica, Morris Kletzel, Reggie Duerst, et al.. (2015). Single Daily Busulfan Dosing for Infants with Nonmalignant Diseases Undergoing Reduced-Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(9). 1612–1621. 10 indexed citations
11.
Pham, Huy P., Joseph E. Schwartz, Laura Cooling, et al.. (2015). Report of the ASFA apheresis registry study on Wilson's disease. Journal of Clinical Apheresis. 31(1). 11–15. 34 indexed citations
12.
Schneiderman, Jennifer, Irene Helenowski, Elaine Morgan, et al.. (2014). Secondary malignant neoplasms after high‐dose chemotherapy and autologous stem cell rescue for high‐risk neuroblastoma. Pediatric Blood & Cancer. 61(8). 1350–1356. 31 indexed citations
13.
Delaney, Meghan, Kelley E. Capocelli, Anne F. Eder, et al.. (2013). An international survey of pediatric apheresis practice. Journal of Clinical Apheresis. 29(2). 120–126. 14 indexed citations
14.
Schneiderman, Jennifer, et al.. (2010). The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low‐weight children: A novel procedure. Journal of Clinical Apheresis. 25(2). 63–69. 26 indexed citations
15.
Tse, William, et al.. (2009). Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant. Bone Marrow Transplantation. 44(3). 145–156. 26 indexed citations
16.
Schneiderman, Jennifer, Wendy B. London, Garrett M. Brodeur, et al.. (2008). Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(6). 913–918. 50 indexed citations
17.
Schneiderman, Jennifer. (2008). Non-Pharmacologic Strategies in Hematopoietic Stem Cell Transplantation. Current Pharmaceutical Design. 14(20). 1987–1996.
18.
Schneiderman, Jennifer, et al.. (2007). Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann‐Pick type B. Pediatric Blood & Cancer. 49(7). 987–989. 12 indexed citations
19.
20.
Schneiderman, Jennifer, Diane J. Nugent, & Guy Young. (2004). Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia. 10(4). 347–351. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026